Literature DB >> 10611458

Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats.

T Kosasa1, Y Kuriya, K Matsui, Y Yamanishi.   

Abstract

Donepezil hydrochloride (donepezil: E2020: (+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one monohydrochloride)) is a centrally acting acetylcholinesterase inhibitor developed for the treatment of Alzheimer's disease. In the present study, its inhibitory effect on the activity of cholinesterase ex vivo was evaluated in the brain, plasma, erythrocytes, heart, small intestine, liver and pectoral muscle of young adult as well as aged rats, in comparison with that of tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride). In aged animals, cholinesterase activity in heart, small intestine and pectoral muscle was lower, whereas that in plasma and liver was higher than in young rats. Both groups showed the highest levels in the brain. Donepezil, at doses of 1.25, 2.5 and 5 mg/kg, p.o., inhibited brain, plasma, erythrocyte, liver and pectoral muscle cholinesterase activity in young rats in a dose-dependent manner but had less effect on cholinesterase activity in heart and small intestine. In aged animals, inhibition of cholinesterase activity in the brain, erythrocytes and pectoral muscle by donepezil was more potent than that in young animals. Tacrine, at doses of 5, 10 and 20 mg/kg, p.o., dose-dependently inhibited cholinesterase activity in all tissues of both young and aged animals, but most potently in heart, small intestine and liver. The inhibition of cholinesterase activity by tacrine in the brain, plasma, erythrocytes, heart and liver was more potent in aged rats than in tissues of young rats. Brain and plasma concentrations of unchanged donepezil and tacrine were measured in the same animals as used for the cholinesterase inhibition study. Brain and plasma concentrations of donepezil and tacrine were higher in aged than in young animals. It is concluded that the inhibitory effects of donepezil and tacrine on cholinesterase activity are greater in aged than in young rats, owing to differences in the tissue concentrations of these compounds between young and aged animals. It is also suggested that the effect of donepezil on cholinesterase activity is more tissue-selective than that of tacrine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611458     DOI: 10.1016/s0014-2999(99)00741-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

2.  Effects on cholinergic markers in rat brain and blood after short and prolonged administration of donepezil.

Authors:  Kristin Huse Haug; Inger Lise Bogen; Harald Osmundsen; Ivar Walaas; Frode Fonnum
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET.

Authors:  Nisha K Ramakrishnan; Anniek K D Visser; Marianne Schepers; Gert Luurtsema; Csaba J Nyakas; Philip H Elsinga; Kiichi Ishiwata; Rudi A J O Dierckx; Aren van Waarde
Journal:  Psychopharmacology (Berl)       Date:  2014-03-18       Impact factor: 4.530

4.  Cholinergic enhancement increases the effects of voluntary attention but does not affect involuntary attention.

Authors:  Ariel Rokem; Ayelet N Landau; Dave Garg; William Prinzmetal; Michael A Silver
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

5.  Cholinergic enhancement augments magnitude and specificity of visual perceptual learning in healthy humans.

Authors:  Ariel Rokem; Michael A Silver
Journal:  Curr Biol       Date:  2010-09-16       Impact factor: 10.834

6.  Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.

Authors:  Tatsuya Kikuchi; Toshimitsu Okamura; Takuya Arai; Takayuki Obata; Kiyoshi Fukushi; Toshiaki Irie; Tetsuya Shiraishi
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

7.  The effect of donepezil treatment on cardiovascular mortality.

Authors:  K Sato; R Urbano; C Yu; F Yamasaki; T Sato; J Jordan; D Robertson; A Diedrich
Journal:  Clin Pharmacol Ther       Date:  2010-07-21       Impact factor: 6.875

Review 8.  Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.

Authors:  Muriel Noetzli; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

9.  Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits.

Authors:  Aldis P Weible; M Matthew Oh; Grace Lee; John F Disterhoft
Journal:  Learn Mem       Date:  2004 Jan-Feb       Impact factor: 2.460

10.  Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.

Authors:  D S Woodruff-Pak; R W Vogel; G L Wenk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.